博济医药：子公司卿芷软膏获药物临床试验批准通知书

Core Viewpoint - The announcement indicates that the company's subsidiary, Guangzhou Boji New Drug Clinical Research Center Co., Ltd., has received approval from the National Medical Products Administration for the clinical trial of "Qingzhi Ointment," a new traditional Chinese medicine formulation [1] Group 1 - "Qingzhi Ointment" is a new prescription formulation based on traditional Chinese medicine theory and is classified as a Class 1 innovative traditional Chinese medicine [1] - The ointment is intended for the treatment of knee osteoarthritis with symptoms of wind-cold-dampness, focusing on dispelling wind, eliminating dampness, relieving cold, promoting circulation, and alleviating pain [1]